Acquisition by Gail Farfel of 5500 shares of Durect at 5.29 subject to Rule 16b-3
DRRX Stock | USD 0.88 0.03 3.30% |
Slightly above 53% of Durect's investors are presently thinking to get in. The analysis of overall sentiment of trading Durect stock suggests that some investors are interested at this time. Durect's investing sentiment can be driven by a variety of factors including economic data, Durect's earnings reports, geopolitical events, and overall market trends.
Durect |
Filed transaction by Durect Director. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Durect's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Durect's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Durect Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Durect can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Durect Fundamental Analysis
We analyze Durect's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Durect using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Durect based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Durect is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Durect Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Durect stock to make a market-neutral strategy. Peer analysis of Durect could also be used in its relative valuation, which is a method of valuing Durect by comparing valuation metrics with similar companies.
Peers
Durect Related Equities
PASG | Passage Bio | 68.66 | ||||
LYEL | Lyell Immunopharma | 3.26 | ||||
CNTB | Connect Biopharma | 2.91 | ||||
DSGN | Design Therapeutics | 0.50 | ||||
FOLD | Amicus Therapeutics | 0.20 | ||||
ORIC | Oric Pharmaceuticals | 0.70 | ||||
CRNX | Crinetics Pharmaceuticals | 0.81 | ||||
LGND | Ligand Pharmaceuticals | 0.88 | ||||
RVMD | Revolution Medicines | 1.25 | ||||
ENTA | Enanta Pharmaceuticals | 2.60 |
Additional Tools for Durect Stock Analysis
When running Durect's price analysis, check to measure Durect's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Durect is operating at the current time. Most of Durect's value examination focuses on studying past and present price action to predict the probability of Durect's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Durect's price. Additionally, you may evaluate how the addition of Durect to your portfolios can decrease your overall portfolio volatility.